Metagone Biotech Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers (NCT03650075) | Metagone Biotech Inc. | 2019-02-25 |
| Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid Tumor (NCT03406364) | Metagone Biotech Inc. | 2018-06-06 |
Track Metagone Biotech Inc. automatically
Every clearance here is in the API, with alerts when new ones post.